{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:48:51Z","timestamp":1785797331654,"version":"3.56.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.japh.2023.10.029","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T14:45:01Z","timestamp":1698677101000},"page":"186-196.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pharmacy-based sexually transmitted infection service implementation considerations: A scoping review"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7101-8994","authenticated-orcid":false,"given":"Mackenzie","family":"d\u2019Entremont-Harris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"MacNabb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1670-2512","authenticated-orcid":false,"given":"Kyle John","family":"Wilby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9435-9377","authenticated-orcid":false,"given":"Tasha D.","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.japh.2023.10.029_bib4","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/cid\/ciz429","article-title":"Chlamydia trachomatis and the risk of pelvic inflammatory disease, ectopic pregnancy, and female infertility: a retrospective cohort study Among primary care patients","volume":"69","author":"den Heijer","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.japh.2023.10.029_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.clindermatol.2013.08.010","article-title":"Gonorrhea: new challenges","volume":"32","author":"Skerlev","year":"2014","journal-title":"Clin Dermatol"},{"issue":"9","key":"10.1016\/j.japh.2023.10.029_bib6","first-page":"723","article-title":"Epididymitis: an overview","volume":"94","author":"McConaghy","year":"2016","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.japh.2023.10.029_bib8","series-title":"StatPearls","article-title":"Syphilis","author":"Tudor","year":"2023"},{"issue":"6","key":"10.1016\/j.japh.2023.10.029_bib10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/OLQ.0000000000000980","article-title":"Proportion of Incident human immunodeficiency virus cases among men who have sex with men Attributable to gonorrhea and Chlamydia: a Modeling analysis","volume":"46","author":"Jones","year":"2019","journal-title":"Sex Transm Dis"},{"issue":"4","key":"10.1016\/j.japh.2023.10.029_bib11","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/QAI.0b013e3181c3ef29","article-title":"Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV Seroconversion","volume":"53","author":"Bernstein","year":"2010","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"10078","key":"10.1016\/j.japh.2023.10.029_bib12","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(16)32411-4","article-title":"Syphilis","volume":"389","author":"Hook","year":"2017","journal-title":"Lancet Lond Engl"},{"issue":"2","key":"10.1016\/j.japh.2023.10.029_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3390\/healthcare8020143","article-title":"Global scope of Hospital pharmacy practice: a scoping review","volume":"8","author":"Ahmed Abousheishaa","year":"2020","journal-title":"Healthcare"},{"issue":"1","key":"10.1016\/j.japh.2023.10.029_bib14","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1186\/s12889-020-08719-0","article-title":"Expanding access to HIV testing through Canadian community pharmacies: findings from the APPROACH study","volume":"20","author":"Kelly","year":"2020","journal-title":"BMC Publ Health"},{"issue":"3","key":"10.1016\/j.japh.2023.10.029_bib15","first-page":"106","article-title":"Community-based pharmacy practice innovation and the role of the community-based pharmacist practitioner in the United States","volume":"7","author":"Goode","year":"2019","journal-title":"Pharm J Pharm Educ Pract"},{"issue":"7","key":"10.1016\/j.japh.2023.10.029_bib17","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1503\/cmaj.045019","article-title":"Effects of making emergency contraception available without a physician\u2019s prescription: a population-based study","volume":"172","author":"Soon","year":"2005","journal-title":"CMAJ Can Med Assoc J"},{"issue":"12","key":"10.1016\/j.japh.2023.10.029_bib18","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/S0277-9536(03)00129-1","article-title":"Supplying emergency contraception via community pharmacies in the UK: reflections on the experiences of users and providers","volume":"57","author":"Bissell","year":"2003","journal-title":"Soc Sci Med"},{"issue":"1","key":"10.1016\/j.japh.2023.10.029_bib19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/humrep\/dei287","article-title":"Community pharmacy supply of emergency hormonal contraception: a structured literature review of international evidence","volume":"21","author":"Anderson","year":"2006","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.japh.2023.10.029_bib20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/0897190013516507","article-title":"Emergency contraception counseling in a retail pharmacy setting: a pilot study","volume":"28","author":"Ragland","year":"2015","journal-title":"J\u00a0Pharm Pract"},{"issue":"6","key":"10.1016\/j.japh.2023.10.029_bib21","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/17151635211034534","article-title":"Enhancing access to contraception through pharmacist prescribing across Canada","volume":"154","author":"Soon","year":"2021","journal-title":"Can Pharm J CPJ"},{"issue":"4","key":"10.1016\/j.japh.2023.10.029_bib22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.contraception.2020.07.001","article-title":"Pharmacist prescription and access to hormonal contraception for Medicaid-insured women in Oregon","volume":"102","author":"Gibbs","year":"2020","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.japh.2023.10.029_bib23","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/AOG.0000000000003286","article-title":"Pharmacist provision of hormonal contraception in the Oregon Medicaid population","volume":"133","author":"Anderson","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.japh.2023.10.029_bib24","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/sextrans-2019-054096","article-title":"Pharmacy-based sexual health services: a systematic review of experiences and attitudes of pharmacy users and pharmacy staff","volume":"95","author":"Gauly","year":"2019","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.japh.2023.10.029_bib25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.srhc.2018.03.006","article-title":"Readiness of pharmacists and consumers for pharmacy-based chlamydia screening in Australia and Switzerland","volume":"16","author":"Arnet","year":"2018","journal-title":"Sex Reprod Healthc"},{"issue":"12","key":"10.1016\/j.japh.2023.10.029_bib26","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1471-0528.2007.01506.x","article-title":"Willingness of gynaecologists, doctors in family planning, GPs, practice nurses and pharmacists to adopt novel interventions for treating sexual partners of women with chlamydia","volume":"114","author":"Cameron","year":"2007","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.japh.2023.10.029_bib27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/ijpp.12042","article-title":"Self-reported risk factors for chlamydia: a survey of pharmacy-based emergency contraception consumers","volume":"22","author":"Gudka","year":"2014","journal-title":"Int J Pharm Pract"},{"issue":"4","key":"10.1016\/j.japh.2023.10.029_bib28","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.japh.2022.01.018","article-title":"Community pharmacists\u2019 provision of sexual and reproductive health services: a cross-sectional study in Alberta, Canada","volume":"62","author":"Navarrete","year":"2022","journal-title":"J\u00a0Am Pharm Assoc"},{"issue":"2_suppl","key":"10.1016\/j.japh.2023.10.029_bib29","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1177\/0033354918801026","article-title":"The \u201cNo Wrong door\u201d approach to HIV testing: results from a Statewide retail pharmacy\u2013based HIV testing program in Virginia, 2014-2016","volume":"133","author":"Collins","year":"2018","journal-title":"Public Health Rep"},{"issue":"4","key":"10.1016\/j.japh.2023.10.029_bib30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/sextrans-2014-051751","article-title":"Engaging young adult clients of community pharmacies for HIV screening in Coastal Kenya: a cross-sectional study","volume":"91","author":"Mugo","year":"2015","journal-title":"Sex Transm Infect"},{"issue":"Suppl 1","key":"10.1016\/j.japh.2023.10.029_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/00333549161310S116","article-title":"Pharmacy intervention to improve HIV testing uptake using a comprehensive health screening approach","volume":"131","author":"Crawford","year":"2016","journal-title":"Public Health Rep"},{"issue":"1","key":"10.1016\/j.japh.2023.10.029_bib32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1331\/JAPhA.2015.14070","article-title":"Pharmacist-provided rapid HIV testing in two community pharmacies","volume":"55","author":"Darin","year":"2015","journal-title":"J\u00a0Am Pharm Assoc"},{"issue":"6","key":"10.1016\/j.japh.2023.10.029_bib33","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/hiv.12224","article-title":"The rapid test in Spanish pharmacies: a novel programme to reach heterosexual men?","volume":"16","author":"Fern\u00e1ndez-Balbuena","year":"2015","journal-title":"HIV Med"},{"issue":"5","key":"10.1016\/j.japh.2023.10.029_bib34","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1331\/JAPhA.2014.14045","article-title":"HIV testing in community pharmacies and retail clinics: a model to expand access to screening for HIV infection","volume":"54","author":"Weidle","year":"2014","journal-title":"J\u00a0Am Pharm Assoc"},{"issue":"4","key":"10.1016\/j.japh.2023.10.029_bib35","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/17151635231177027","article-title":"Target users\u2019 acceptance of a pharmacist-led prescribing service for pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV)","volume":"156","author":"MacDonald","year":"2023","journal-title":"Can Pharm J"},{"key":"10.1016\/j.japh.2023.10.029_bib36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/17151635231152218","article-title":"Community pharmacists\u2019 acceptance of prescribing for pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV)","volume":"156","author":"Booker","year":"2023","journal-title":"Can Pharm J"},{"issue":"10","key":"10.1016\/j.japh.2023.10.029_bib37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/ofid\/ofz365","article-title":"Acceptability and feasibility of a pharmacist-led human immunodeficiency virus pre-exposure prophylaxis program in the Midwestern United States","volume":"6","author":"Havens","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.japh.2023.10.029_bib38","first-page":"32","article-title":"Evaluation of the first year of a pilot program in community pharmacy: HIV\/AIDS medication therapy management for Medi-Cal beneficiaries","volume":"15","author":"Hirsch","year":"2009","journal-title":"J\u00a0Manag Care Pharm"},{"issue":"7","key":"10.1016\/j.japh.2023.10.029_bib39","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.japh.2023.10.029_bib40","series-title":"Covidence Systematic Review Software","year":"2022"},{"issue":"9","key":"10.1016\/j.japh.2023.10.029_bib44","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-052228","article-title":"Young people\u2019s perceptions of accessing a community pharmacy for a chlamydia testing kit: a qualitative study based in North East England","volume":"11","author":"Ahmaro","year":"2021","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.japh.2023.10.029_bib43","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ijpp\/riac057","article-title":"Investigating community pharmacists\u2019 perceptions of delivering chlamydia screening to young people: a qualitative study using normalisation process theory to understand professional practice","volume":"30","author":"Ahmaro","year":"2022","journal-title":"Int J Pharm Pract"},{"issue":"1","key":"10.1016\/j.japh.2023.10.029_bib45","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11096-010-9460-3","article-title":"A\u00a0pharmacy-based private chlamydia screening programme: results from the first 2 years of screening and treatment","volume":"33","author":"Anderson","year":"2011","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"10.1016\/j.japh.2023.10.029_bib42","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/qshc.2006.020883","article-title":"Chlamydia testing in community pharmacies: evaluation of a feasibility pilot in south east London","volume":"16","author":"Baraitser","year":"2007","journal-title":"Qual Saf Health Care"},{"key":"10.1016\/j.japh.2023.10.029_bib46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-6874-9-7","article-title":"Delivery of chlamydia screening to young women requesting emergency hormonal contraception at pharmacies in Manchester, UK: a prospective study","volume":"9","author":"Brabin","year":"2009","journal-title":"BMC Wom Health"},{"issue":"1","key":"10.1016\/j.japh.2023.10.029_bib47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/jfprhc.2010.0003","article-title":"Chlamydia screening by community pharmacists: a qualitative study","volume":"37","author":"Dabrera","year":"2011","journal-title":"J\u00a0Fam Plann Reprod Health Care"},{"issue":"8","key":"10.1016\/j.japh.2023.10.029_bib48","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/sextrans-2014-051994","article-title":"Developing and testing accelerated partner therapy for partner notification for people with genital Chlamydia trachomatis diagnosed in primary care: a pilot randomised controlled trial","volume":"91","author":"Estcourt","year":"2015","journal-title":"Sex Transm Infect"},{"issue":"2","key":"10.1016\/j.japh.2023.10.029_bib41","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/sti.2006.022657","article-title":"Sexually transmitted and reproductive tract infections in symptomatic clients of pharmacies in Lima, Peru","volume":"83","author":"Garc\u00eda","year":"2007","journal-title":"Sex Transm Infect"},{"issue":"4","key":"10.1016\/j.japh.2023.10.029_bib49","first-page":"206","article-title":"Staff and users\u2019 experiences of pharmacy-based sexual and reproductive health services: a qualitative Interview study from the UK","volume":"8","author":"Gauly","year":"2020","journal-title":"Pharm J Pharm Educ Pract"},{"issue":"8","key":"10.1016\/j.japh.2023.10.029_bib51","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003338","article-title":"To develop and measure the effectiveness and acceptability of a pharmacy-based chlamydia screening intervention in Australia","volume":"3","author":"Gudka","year":"2013","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.japh.2023.10.029_bib52","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1071\/PY12135","article-title":"\u2018Catching chlamydia\u2019: combining cash incentives and community pharmacy access for increased chlamydia screening, the view of young people","volume":"21","author":"Parker","year":"2015","journal-title":"Aust J Prim Health"},{"issue":"1","key":"10.1016\/j.japh.2023.10.029_bib50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1471-0528.2009.02362.x","article-title":"A\u00a0qualitative study of pharmacists\u2019 views on offering chlamydia screening to women requesting emergency hormonal contraception: pharmacy chlamydia screening after emergency contraception","volume":"117","author":"Thomas","year":"2010","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.japh.2023.10.029_bib53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/j.2055-2335.2013.tb00208.x","article-title":"Future pharmacy-based chlamydia screening: Consumer preference","volume":"43","author":"Gudka","year":"2013","journal-title":"J\u00a0Pharm Pract Res"},{"issue":"6","key":"10.1016\/j.japh.2023.10.029_bib54","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2105\/AJPH.2019.305057","article-title":"Pharmacists in HIV prevention: an untapped potential","volume":"109","author":"Myers","year":"2019","journal-title":"Am J Public Health"},{"issue":"12","key":"10.1016\/j.japh.2023.10.029_bib55","doi-asserted-by":"crossref","DOI":"10.2196\/jmir.2628","article-title":"Young Men\u2019s views toward the barriers and facilitators of internet-based chlamydia trachomatis screening: qualitative study","volume":"15","author":"Lorimer","year":"2013","journal-title":"J\u00a0Med Internet Res"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319123003527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319123003527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:54:18Z","timestamp":1761544458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319123003527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1544319123003527"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2023.10.029","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacy-based sexually transmitted infection service implementation considerations: A scoping review","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2023.10.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of the American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}